MedPath
FDA Approval

ONDANSETRON

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
December 27, 2011
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Ondansetron(8 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Rebel Distributors Corp

Rebel Distributors Corp

118802834

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ONDANSETRON

Product Details

NDC Product Code
42254-097
Application Number
ANDA077557
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
November 16, 2009
Code: 4AF302ESOSClass: ACTIBQuantity: 8 mg in 1 1
ASPARTAMEInactive
Code: Z0H242BBR1Class: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
GLYCERYL DISTEARATEInactive
Code: 73071MW2KMClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT

ONDANSETRON

Product Details

NDC Product Code
42254-077
Application Number
ANDA077557
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
November 16, 2009
Code: 4AF302ESOSClass: ACTIBQuantity: 4 mg in 1 1
ASPARTAMEInactive
Code: Z0H242BBR1Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
GLYCERYL DISTEARATEInactive
Code: 73071MW2KMClass: IACT
© Copyright 2025. All Rights Reserved by MedPath